Methylation framework of cell cycle gene inhibitors in cirrhosis and associated hepatocellular carcinoma

Lin, 1998, Infrequent mutations and no methylation of CDKN2A (P16/MTS1) and CDKN2B (p15/MTS2) in hepatocellular carcinoma in Taiwan, Eur J Cancer, 34, 1789, 10.1016/S0959-8049(98)00189-0 Liew, 1999, High frequency of p16INK4A gene alterations in hepatocellular carcinoma, Oncogene, 18, 789, 10.1038/sj.onc.1202359 Matsuda, 1999, p16(INK4) is inactivated by extensive CpG methylation in human hepatocellular carcinoma, Gastroenterology, 116, 394, 10.1016/S0016-5085(99)70137-X Jin, 2000, p16 is a major inactivation target in hepatocellular carcinoma, Cancer, 89, 60, 10.1002/1097-0142(20000701)89:1<60::AID-CNCR9>3.0.CO;2-3 Wong, 1999, Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients, Cancer Res, 59, 71 Kaneto, 2001, Detection of hypermethylation of the p16(INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus, Gut, 48, 372, 10.1136/gut.48.3.372 Bostrom, 2001, Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF), CDKN2B (p15(INK4b)), and CDKN2C (p18(INK4c)) in atypical and anaplastic meningiomas, Am J Pathol, 159, 661, 10.1016/S0002-9440(10)61737-3 Nakamura, 2001, Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphoma, Cancer Res, 61, 6335 Dong, 2001, Concurrent hypermethylation of multiple genes is associated with grade of oligodendroglial tumors, J Neuropathol Exp Neurol, 60, 808, 10.1093/jnen/60.8.808 Belinsky, 1998, Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis, Proc Natl Acad Sci U S A, 95, 11891, 10.1073/pnas.95.20.11891 Hsieh, 1998, Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis, Cancer Res, 58, 3942 Klump, 1998, Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus, Gastroenterology, 115, 1381, 10.1016/S0016-5085(98)70016-2 Wilentz, 1998, Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression, Cancer Res, 58, 4740 Wong, 2000, Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients, Clin Cancer Res, 6, 3516 Herman, 1996, Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands, Proc Natl Acad Sci U S A, 93, 9821, 10.1073/pnas.93.18.9821 Ozturk, 1999, Genetic aspects of hepatocellular carcinogenesis, Semin Liver Dis, 19, 235, 10.1055/s-2007-1007113 Buendia, 2000, Genetics of hepatocellular carcinoma, Semin Cancer Biol, 10, 185, 10.1006/scbi.2000.0319 Kondo, 2000, Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis-a comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma, Hepatology, 32, 970, 10.1053/jhep.2000.19797 Roncalli, 2000, Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up, Hepatology, 31, 846, 10.1053/he.2000.5790 Maggioni, 2000, Molecular changes in hepatocellular dysplastic nodules on microdissected liver biopsies, Hepatology, 32, 942, 10.1053/jhep.2000.18425 Shim, 2000, Correlation of p16 hypermethylation with p16 protein loss in sporadic gastric carcinomas, Lab Invest, 80, 689, 10.1038/labinvest.3780072 Garcia, 1999, Loss of p16 protein expression associated with methylation of the p16INK4A gene is a frequent finding in Hodgkin's disease, Lab Invest, 79, 1453